BACKGROUND: Major depressive disorder (MDD) and anxiety disorders are highly comorbid, sharing many similar symptoms, including impairments in cognitive control. Deficits in cognitive control could be a potential mechanism underlying impaired emotion regulation in mood disorders. METHODS: Participants were 44 individuals with no history of mental illness (healthy controls, HC), 31 individuals in the remitted state of MDD (rMDD), and 18 individuals who met lifetime DSM-IV-TR criteria for rMDD and an anxiety disorder in remission (Comorbid). Participants completed a Parametric Go/No-Go (PGNG) test during fMRI. Event-related analyses modeled activity for cognitive control successes (Hits for Targets, Rejections for Lures) and failures (Commissions on Lures) on the PGNG task. RESULTS: The rMDD group showed significantly reduced activity within the cognitive control network (CCN) during Commission errors, including the middle frontal gyrus and inferior parietal lobule (IPL). The Comorbid group showed significantly reduced activity in several clusters within the CCN during correct Rejections, including the left IPL and right inferior frontal gyrus and greater subgenual cingulate. Notably, during correct Rejections, 60% of activation for the Comorbid group was within the Salience and Emotion Network (SEN), with 0% within the CCN. LIMITATIONS: The size of the Comorbid subgroup was modest, preventing subanalysis of the different AD subtypes. CONCLUSIONS: There is evidence that CCN activity declines in rMDD and that there may be compensatory SEN activity in individuals with Comorbid rMDD and anxiety. Our findings support the identification of comorbid anxiety as a meaningful subtype of MDD that may obscure group differences between rMDD and HCs.
BACKGROUND: Major depressive disorder (MDD) and anxiety disorders are highly comorbid, sharing many similar symptoms, including impairments in cognitive control. Deficits in cognitive control could be a potential mechanism underlying impaired emotion regulation in mood disorders. METHODS:Participants were 44 individuals with no history of mental illness (healthy controls, HC), 31 individuals in the remitted state of MDD (rMDD), and 18 individuals who met lifetime DSM-IV-TR criteria for rMDD and an anxiety disorder in remission (Comorbid). Participants completed a Parametric Go/No-Go (PGNG) test during fMRI. Event-related analyses modeled activity for cognitive control successes (Hits for Targets, Rejections for Lures) and failures (Commissions on Lures) on the PGNG task. RESULTS: The rMDD group showed significantly reduced activity within the cognitive control network (CCN) during Commission errors, including the middle frontal gyrus and inferior parietal lobule (IPL). The Comorbid group showed significantly reduced activity in several clusters within the CCN during correct Rejections, including the left IPL and right inferior frontal gyrus and greater subgenual cingulate. Notably, during correct Rejections, 60% of activation for the Comorbid group was within the Salience and Emotion Network (SEN), with 0% within the CCN. LIMITATIONS: The size of the Comorbid subgroup was modest, preventing subanalysis of the different AD subtypes. CONCLUSIONS: There is evidence that CCN activity declines in rMDD and that there may be compensatory SEN activity in individuals with Comorbid rMDD and anxiety. Our findings support the identification of comorbid anxiety as a meaningful subtype of MDD that may obscure group differences between rMDD and HCs.
Authors: J L Lancaster; M G Woldorff; L M Parsons; M Liotti; C S Freitas; L Rainey; P V Kochunov; D Nickerson; S A Mikiten; P T Fox Journal: Hum Brain Mapp Date: 2000-07 Impact factor: 5.038
Authors: Tim P Moran; Ed M Bernat; Selin Aviyente; Hans S Schroder; Jason S Moser Journal: Soc Cogn Affect Neurosci Date: 2015-04-28 Impact factor: 3.436
Authors: Lucile Capuron; Giuseppe Pagnoni; Marina Demetrashvili; Bobbi J Woolwine; Charles B Nemeroff; Gregory S Berns; Andrew H Miller Journal: Biol Psychiatry Date: 2005-08-01 Impact factor: 13.382
Authors: Marie-José van Tol; Liliana R Demenescu; Nic J A van der Wee; Rudie Kortekaas; Nielen Marjan M A; J A Den Boer; Remco J Renken; Mark A van Buchem; Frans G Zitman; André Aleman; Dick J Veltman Journal: Biol Psychiatry Date: 2011-12-28 Impact factor: 13.382
Authors: Femke Lamers; Patricia van Oppen; Hannie C Comijs; Johannes H Smit; Philip Spinhoven; Anton J L M van Balkom; Willem A Nolen; Frans G Zitman; Aartjan T F Beekman; Brenda W J H Penninx Journal: J Clin Psychiatry Date: 2011-01-25 Impact factor: 4.384
Authors: H Johansen-Berg; D A Gutman; T E J Behrens; P M Matthews; M F S Rushworth; E Katz; A M Lozano; H S Mayberg Journal: Cereb Cortex Date: 2007-10-10 Impact factor: 5.357